The response of PIK3CA/KRAS-mutant colorectal cancer stem-like cells to RGD-peptide FraC produced by the strawberry anemone: A promising water-soluble peptide-based inhibitor of metastasis-driver gene CXCR4, stem cell regulatory genes and self-renewal -
Aspirin sensitivity of PIK3CA-mutated Colorectal Cancer: potential mechanisms revisited | Cellular and Molecular Life Sciences
PIK3CA Mutations Frequently Coexist with RAS and BRAF Mutations in Patients with Advanced Cancers | PLOS ONE
Aspirin Use Not Associated With Survival in PIK3CA-Mutant Colorectal Cancer - The ASCO Post
PIK3CA in Colorectal Cancer. - Abstract - Europe PMC
Knockin of mutant PIK3CA activates multiple oncogenic pathways | PNAS
Molecular Detection of Colorectal Cancer | Encyclopedia MDPI
KRAS, NRAS, BRAF, and PIK3CA mutation rates, clinicopathological association, and their prognostic value in Iranian colorectal cancer patients - Mirzapoor Abbasabadi - 2023 - Journal of Clinical Laboratory Analysis - Wiley Online Library
Aspirin Use, Tumor PIK3CA Mutation, and Colorectal-Cancer Survival | NEJM
Targeting PI3K Signaling as a Therapeutic Approach for Colorectal Cancer - ScienceDirect
PIK3CA Biomarker | Colorectal Cancer Alliance
Cancer-Associated PIK3CA Mutations in Overgrowth Disorders: Trends in Molecular Medicine
Prognostic value of the PIK3CA, AKT, and PTEN mutations in oral squamous cell carcinoma: literature review
Summary for our hypothesis in MEK inhibitor-resistant PIK3CA mt colon... | Download Scientific Diagram
Prevalence and characteristics of PIK3CA mutation in mismatch repair-deficient colorectal cancer
PIK3CA Biomarker | Colorectal Cancer Alliance
PIK3CA mutations-mediated downregulation of circLHFPL2 inhibits colorectal cancer progression via upregulating PTEN | Molecular Cancer | Full Text
Portrait of the PI3K/AKT pathway in colorectal cancer - ScienceDirect
Mortality among Patients with Colorectal Cancer, According to Regular... | Download Scientific Diagram
Clinical Characteristics and Prognostic Values of PIK3CA Mutation in Colorectal Cancer Patients
PIK3CA (3q26.3) Orange + Copy Control 3 FISH Probe - Biocare Medical
PIK3CA point mutation rates in TCGA cohorts. Analysis of TCGA cohorts... | Download Scientific Diagram
Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis - The Lancet Oncology
Combined analysis of KRAS and PIK3CA mutations, MET and PTEN expression in primary tumors and corresponding metastases in colorectal cancer - Modern Pathology
